43 results on '"Booth‐Jones, Margaret"'
Search Results
2. Worsening cognitive performance is associated with increases in systemic inflammation following hematopoietic cell transplantation
3. Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma
4. Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell Therapy
5. The Role of Age in Neurocognitive Functioning among Adult Allogeneic Hematopoietic Cell Transplant Recipients
6. Cognition in patients treated with targeted therapy for chronic myeloid leukemia: a controlled comparison
7. Sarcopenia Prevalence and Influence on the Development of Toxicity and Length of Stay in Patients with Relapsed and Refractory Myeloma Treated with Commercial Anti-BCMA CART Cells
8. Change in neurocognitive performance among patients with non-Hodgkin’s lymphoma in the first year after CAR T-cell therapy
9. Cognition in patients treated with targeted therapy for chronic myeloid leukemia: a controlled comparison.
10. Change in Patients' Perceived Cognition Among Chimeric Antigen Receptor T-Cell Therapy Recipients at Day 360
11. Quality of life in caregivers of patients receiving chimeric antigen receptor T‐cell therapy
12. COVID-19 pandemic causing medical and public health ethical dilemmas: A case report and review of literature
13. Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel
14. Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers
15. Predictors of posttraumatic stress disorder symptomatology following bone marrow transplantation for cancer. (Brief Reports)
16. Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation
17. Anaplastic Astrocytoma
18. Neurocognitive Impairment in Children Treated for Cancer: How Do We Measure Cognitive Outcomes?
19. Changes in cognitive functioning in the year after hematopoietic stem cell transplantation
20. Alcoholism, depression, and abnormal cognition in head and neck cancer: A pilot study
21. VALIDATION OF THE DISTRESS THERMOMETER WITH BONE MARROW TRANSPLANT PATIENTS
22. Cognitive Impairment in Patients With Brain Tumors: Assessment and Intervention in the Clinic Setting
23. Predictors of Posttraumatic Growth Following Bone Marrow Transplantation for Cancer
24. Apathy and Pituitary Disease: It Has Nothing to Do With Depression
25. Patient-Reported and Neurocognitive Outcomes in Patients Treated with Axicabtagene Ciloleucel
26. Preliminary Evaluation of a Clinical Syndrome Approach to Assessing Cancer-Related Fatigue
27. 459 - Patient-Reported Toxicities in Axicabtagene Ciloleucel Recipients: 1-Year Follow-up
28. Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers: Neurocognition and Brain Metastases
29. The Role of Age in Neurocognitive Functioning among Adult Allogeneic Hematopoietic Cell Transplant Recipients.
30. Association of frailty and high-risk immuno-nutritional score with outcomes in patients with relapsed and refractory multiple myeloma treated with chimeric antigen receptor T-cells.
31. Clinical Predictors of Cognitive Function in Adults Treated with Hematopoietic Cell Transplant
32. Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison
33. Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients
34. Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation
35. O3-07-07: Potential Alzheimer's treatments GM-CSF and G-CSF improve cognition in cancer patients
36. Do Coping and Social Support Predict Depression and Anxiety in Patients Undergoing Hematopoietic Stem Cell Transplantation?
37. Evaluation of the Functional Assessment of Cancer Therapy Cognitive Scale with Hematopoetic Stem Cell Transplant Patients
38. Pilot testing of the computerized cognitive test Microcog™ in chemotherapy-treated older cancer patients
39. Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy
40. "Joubert Syndrome" Revisited: Key Ocular Motor Signs With Magnetic Resonance Imaging Correlation
41. Patient-Reported Toxicities in Axicabtagene Ciloleucel Recipients: 1-Year Follow-up
42. Potential Alzheimer's treatments GM-CSF and G-CSF improve cognition in cancer patients.
43. Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.